The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGenTrial conducted and funded by the ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious disease of the liver.Wegovy can be used for patients suffering from ...

In a highly unusual move, a small biotech has disclosed a rejection letter from the FDA in hopes of rallying support for ...

Two California universites are about to start teaching how to turn party drugs into non-party drugs. For millions, that could ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Health and Human Services Secretary Robert F Kennedy Jr will not target ultra-processed foods or pesticides as part of his ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at ...

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...